Ansbro É, Masri S, Prieto-Merino D, Willis R, Aoun Bahous S, et al.
2023-01-25 • BMJ Open
2023-01-25 • BMJ Open
OBJECTIVES This pre–post implementation study evaluated the introduction of fixed dose combination (FDC) medications for atherosclerotic cardiovascular disease (ASCVD) secondary prev...
Siender M, Bibangambah P, Kim JH, Lankowski A, Chang JL, et al.
2021-06-15 • Journal of the American Heart Association
2021-06-15 • Journal of the American Heart Association
BACKGROUND Although ≈70% of the world's population of people living with HIV resides in sub-Saharan Africa, there are minimal prospective data on the contributions of HIV infection t...
We are not alone in welcoming the study by Kelly E Dooley and colleagues 1 that sheds light on the QT prolonging effects of the combination of bedaquiline and delamanid, two key drugs fo...
Webster R, Murphy A, Bygrave H, Ansbro É, Grobbee DE, et al.
2019-12-31 • Global Heart
2019-12-31 • Global Heart
HIGHLIGHTS -- Despite clinical evidence of its effectiveness in secondary prevention of cardiovascular disease, uptake of fixed dose combination therapy (FDCs) for CVD has been poor....
Muhame RM, Dragulescu A, Nadimpalli A, Martinez D, Bottineau MC, et al.
2021-03-08 • Cardiology in the Young
2021-03-08 • Cardiology in the Young
Background: In resource limited settings, children with cardiac disease present late, have poor outcomes and access to paediatric cardiology programmes is limited. Cardiac point of care ...
Muiru AN, Bibangambah P, Hemphill LC, Sentongo R, Kim JH, et al.
2018-04-11 • Journal of Acquired Immune Deficiency Syndromes (1999)
2018-04-11 • Journal of Acquired Immune Deficiency Syndromes (1999)
BACKGROUND The utility and validity of cardiovascular diseases (CVD) risk scores are not well studied in sub-Saharan Africa. We compared and correlated CVD risk scores with carotid i...
Ansbro E, Masri S, Prieto-Merino D, Bahous SA, Molfino L, et al.
2022-05-11 • MSF Scientific Days International 2022
2022-05-11 • MSF Scientific Days International 2022
INTRODUCTION Cardiovascular disease (CVD) is the leading cause of death and disability globally, including in humanitarian contexts. Fixed-dose combination (FDC) drugs are cost-effec...
Ansbro É, Homan T, Jobanputra K, Qasem J, Muhammad S, et al.
2021-01-11 • PLOS Medicine
2021-01-11 • PLOS Medicine
BACKGROUND Little is known about the content or quality of non-communicable disease (NCD) care in humanitarian settings. Since 2014, Médecins Sans Frontières (MSF) has provided prima...
Vetter B, Beran D, Boulle P, Chua AC, de la Tour R, et al.
2021-10-09 • BMC Cardiovascular Disorders
2021-10-09 • BMC Cardiovascular Disorders
INTRODUCTION Multi-parameter diagnostic devices can simplify cardiometabolic disease diagnosis. However, existing devices may not be suitable for use in low-resource settings, where ...
Ansbro É, Homan T, Qasem J, Bil K, Tarawneh M, et al.
2021-04-26 • BMC Health Services Research
2021-04-26 • BMC Health Services Research
BACKGROUND In response to the rising global NCD burden, humanitarian actors have rapidly scaled-up NCD services in crisis-affected low-and-middle income countries. Using the RE-AIM i...
Murphy A, Willis R, Ansbro É, Masri S, Kabbara N, et al.
2022-06-04 • BMC Health Services Research
2022-06-04 • BMC Health Services Research
BACKGROUND We report findings of a qualitative evaluation of fixed-dose combination therapy for patients with established atherosclerotic cardiovascular disease (ASCVD) attending Méd...
